← Back to Clinical Trials
Recruiting NCT06423222

NCT06423222 Anal Incontinence and Its Impact on Quality of Life and Physical Activity Among Hungarian Women and the Hungarian Language Validation of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06423222
Status Recruiting
Phase
Sponsor University of Pecs
Condition Anal Incontinence
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2024-04-22
Primary Completion 2026-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 50 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2024-04-22 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to assess the prevalence of anal incontinence among Hungarian women who have given birth at least once before, and to examine the impact of anal incontinence on the quality of life and physical activity of these women. A further aim of our study is to adapt the Hungarian version of the International Consultation on Incontinence Modular Questionnaire - Bowels (ICIQ-B) and to assess its validity and reliability.

Eligibility Criteria

Inclusion Criteria: * Have given birth at least once before * Native Hungarian language Exclusion Criteria: * Menopause * Irritable Bowel Syndrome (IBS) * Chron's disease * Ulcerative colitis * Developmental abnormalities at the level of the pelvic organs * Uninvestigated pelvic pain * Malignant pelvic tumor * Radiotherapy involving the pelvis * Neurological diseases with muscle weakness * Parkinson's disease * Intellectual disability

Contact & Investigator

Central Contact

Márta Hock, PhD

✉ hock.marta@etk.pte.hu

📞 +36-30-7213156

Principal Investigator

Márta Hock, PhD

STUDY DIRECTOR

University of Pécs Faculty of Health Sciences

Frequently Asked Questions

Who can join the NCT06423222 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Anal Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06423222 currently recruiting?

Yes, NCT06423222 is actively recruiting participants. Contact the research team at hock.marta@etk.pte.hu for enrollment information.

Where is the NCT06423222 trial being conducted?

This trial is being conducted at Pécs, Hungary.

Who is sponsoring the NCT06423222 clinical trial?

NCT06423222 is sponsored by University of Pecs. The principal investigator is Márta Hock, PhD at University of Pécs Faculty of Health Sciences. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology